Clinical Trials Logo

Adnexal Mass clinical trials

View clinical trials related to Adnexal Mass.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04668521 Terminated - Adnexal Mass Clinical Trials

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

OVA360
Start date: May 4, 2020
Phase:
Study type: Observational

The objective of this project is to validate a next-generation assay that utilizes both the protein biomarkers of our already established ovarian cancer risk assessment combined with a molecular profile in both germline and early somatic detection.

NCT ID: NCT04487405 Terminated - Adnexal Mass Clinical Trials

A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants

OVAnex
Start date: June 25, 2020
Phase:
Study type: Observational

The objective of this project is to validate the sensitivity, specificity, positive predictive value and negative predictive values of the AMRA blood test for assessing risk of cancer in women at high risk for ovarian cancer, due to the presence of a symptomatic adnexal mass.

NCT ID: NCT03485651 Terminated - Adnexal Mass Clinical Trials

Natera Ovarian Cancer Detection Assay

Start date: December 14, 2017
Phase:
Study type: Observational

The purpose of this study is to enroll participants who present with an adnexal mass on imaging to develop a non-invasive ovarian cancer assay to distinguish between malignant and benign masses. The study will collect blood, tissue, and health information from these individuals.